Blood-Based Versus Crystalloid Cardiopulmonary Bypass Priming in Left Ventricular Assist Device Surgery: Impact on End-Organ Function and Survival
Interdisciplinary CardioVascular and Thoracic Surgery · 03.08.2026 · 41 (8)
DOI: 10.1093/icvts/ivag216 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Interdisciplinary CardioVascular and Thoracic Surgery, online erschienen am 31.07.2026. Verfasst von Sophie Bonni und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery, University Hospital RWTH Aachen, Aachen 52074, Germany. Hauptthemen laut MEDLINE: Heart-Assist Devices, Cardiopulmonary Bypass, Heart Failure, Crystalloid Solutions. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objectives
Cardiopulmonary bypass (CPB) priming may influence haemodilution, bleeding, and end-organ injury during HeartMate 3 (HM3) implantation, but evidence in contemporary left ventricular assist device (LVAD) surgery is limited.
Methods
We retrospectively analysed 92 HM3 implantations (2015-2025) by priming strategy (blood-based [FFP + RBC], n = 36; crystalloid, n = 56). The primary end-point was postoperative right heart failure (RHF; Interagency Registry for Mechanically Assisted Circulatory Support [INTERMACS]). Multivariable regression and propensity score-based inverse probability of treatment weighting (IPTW) sensitivity analyses were performed.
Results
Baseline characteristics were balanced between groups, with comparable age (blood-based: 58 [49.5-66.0]; crystalloid: 62 [55.8-68.2]; P = .069) and female sex (blood-based: n = 3/36 [8.3%]; crystalloid: n = 8/56 [14.3%]; P = .518). Right heart failure was lower with blood-based priming (blood-based: n = 3/36 [8.3%]; crystalloid: n = 17/56 [30.4%]; P = .012; adjusted OR 0.23 [95% confidence interval (CI) 0.06-0.86]; P = .030). Dialysis was lower unadjusted (blood-based: n = 4/36 [11.1%]; crystalloid: n = 18/56 [32.1%]; P = .021), with a directionally lower adjusted estimate (OR 0.30 [95% CI, 0.09-1.01]; P = .053). Delirium was lower with blood-based priming (blood-based: n = 3/36 [8.3%]; crystalloid: n = 16/56 [28.6%]; P = .019; adjusted OR 0.22 [95% CI, 0.06-0.84]; P = .027). Survival did not differ significantly (log-rank P = .055; adjusted HR 0.59 [95% CI, 0.27-1.32]; P = .201). IPTW analyses showed lower delirium (OR 0.23 [95% CI, 0.06-0.84]) and an attenuated RHF association (OR 0.35 [95% CI, 0.10-1.23]).
Conclusions
Blood-based CPB priming was associated with lower RHF and delirium, and directionally lower dialysis rates, after HM3 implantation. Survival estimates were not statistically significant. Findings require prospective validation. Clinical registration number Ethics Committee of the Medical Faculty of RWTH Aachen (EK 25-154).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiac Surgery, University Hospital RWTH Aachen, Aachen 52074, Germany.
ORCID-Profile: Sophie Bonni, Rashad Zayat, Nima Hatam
Zitieren
APA
Bonni, S., Zayat, R., Ramnath, N. W. M., Hatam, N., Tewarie, L., Moza, A., & Sales, M. C. (2026). Blood-Based Versus Crystalloid Cardiopulmonary Bypass Priming in Left Ventricular Assist Device Surgery: Impact on End-Organ Function and Survival. Interdisciplinary CardioVascular and Thoracic Surgery, 41(8). https://doi.org/10.1093/icvts/ivag216
Vancouver
Bonni S, Zayat R, Ramnath NWM, Hatam N, Tewarie L, Moza A, et al. Blood-Based Versus Crystalloid Cardiopulmonary Bypass Priming in Left Ventricular Assist Device Surgery: Impact on End-Organ Function and Survival. Interdisciplinary CardioVascular and Thoracic Surgery. 2026;41(8). doi:10.1093/icvts/ivag216
BibTeX
@article{Bonni2026,
author = {Bonni, Sophie and Zayat, Rashad and Ramnath, Natasja W M and Hatam, Nima and Tewarie, Lachmandath and Moza, Ajay and Sales, Marjolijn C},
title = {Blood-Based Versus Crystalloid Cardiopulmonary Bypass Priming in Left Ventricular Assist Device Surgery: Impact on End-Organ Function and Survival},
journal = {Interdisciplinary CardioVascular and Thoracic Surgery},
year = {2026},
volume = {41},
number = {8},
doi = {10.1093/icvts/ivag216}
}
EUVIMED